Product Information
MYCOPHENOLIC ACID DR 360 MG TB is a generic product labeled by Accord Healthcare Inc., priced at $0.2216 per EA under NDC 16729018929. Its NADAC has been published 469 times since Oct 11, 2017.
FDA first approved this application on Aug 23, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
360 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729018929
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MYCOPHENOLATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA202555FDA Approved
8/23/2017
TE Code
AB
On Market Since
9/11/2017
Pharmacological Classes
Price Statistics
The NADAC for MYCOPHENOLIC ACID DR 360 MG TB has been published 469 times since Oct 11, 2017, and over the history we have for it it has declined 95.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2216 per EA |
|---|---|
| All-time high | $5.1718 (Dec 13, 2017) |
| All-time low | $0.2114 (Jul 17, 2024) |
| 52-week high | $0.2544 |
| 52-week low | $0.2216 |
| Median price | $0.5671 |
| Average price | $1.4676 |
| Largest weekly change | -43.2% (Mar 23, 2022) |
| Weeks tracked | 469 |
| Tracking since | Oct 11, 2017 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Accord Healthcare Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mycophenolic Acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimetabolite Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MYCOPHENOLIC ACID DR 360 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLIC ACID DR 360 MG TB, manufactured by Accord Healthcare Inc., is $0.2216 per EA (NDC 16729018929), effective Sep 30, 2026.
How has the price of MYCOPHENOLIC ACID DR 360 MG TB changed over time?
Over the history we have for it, the NADAC for MYCOPHENOLIC ACID DR 360 MG TB has declined 95.7%. It has been tracked across 469 weekly CMS publications since Oct 11, 2017.
What are the highest and lowest recorded NADAC prices for MYCOPHENOLIC ACID DR 360 MG TB?
Since Oct 11, 2017, the NADAC for MYCOPHENOLIC ACID DR 360 MG TB has ranged from a low of $0.2114 (Jul 17, 2024) to a high of $5.1718 (Dec 13, 2017), with a median of $0.5671 per EA.
Are there cheaper alternatives to MYCOPHENOLIC ACID DR 360 MG TB?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MYCOPHENOLIC ACID DR 360 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures MYCOPHENOLIC ACID DR 360 MG TB?
MYCOPHENOLIC ACID DR 360 MG TB (NDC 16729018929) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.